Less Common Arthropathies

  • Adel G. Fam


Musculoskeletal manifestions of hematologic and malignant disorders are reviewed in this chapter. A list of these conditions is shown in Table 25A-1.


Carpal Tunnel Syndrome Pyoderma Gangrenosum Diffuse Idiopathic Skeletal Hyperostosis Localize Scleroderma Neutrophilic Dermatosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Peake I. The molecular basis of haemophilia A. Haemophilia 1998;4:346–349.CrossRefPubMedGoogle Scholar
  2. 2.
    Lillicup D. The molecular basis of haemophilia B. Haemophilia 1998;4:350–357.CrossRefGoogle Scholar
  3. 3.
    Hilgartner MW. Current treatment of hemophilic arthropathy. Curr Opin Pediatr 2002;14:46–49.CrossRefPubMedGoogle Scholar
  4. 4.
    Ballas SK. Sickle cell disease: clinical management. Baillieres Clin Hematol 1998;11:185–214.CrossRefGoogle Scholar
  5. 5.
    Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11–16.CrossRefPubMedGoogle Scholar
  6. 6.
    Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol 2005;129:482–490.CrossRefPubMedGoogle Scholar
  7. 7.
    Vichinsky EP, Neumayr LD, Haberkern C, et al. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the national sickle cell surgery study group. Am J Hematol 1999;62:129–138.CrossRefPubMedGoogle Scholar
  8. 8.
    Jacobson SJ, Kopecky EA, Joshi P, Babul N. Randomized trial of oral morphine for painful episodes of sickle-cell disease in children. Lancet 1997;350:1358–1361.CrossRefPubMedGoogle Scholar
  9. 9.
    Moore RD, Charache S, Terrin ML, et al. Cost-effectiveness of hydroxyurea in sickle cell anemia. Am J Hematol 2000;64:26–31.CrossRefPubMedGoogle Scholar
  10. 10.
    Perrine SP, Boosalis V. Thalassemia. In: Rakel RE, Bope ET, eds. Conn’s current therapy. Philadelphia: Saunders (Elsevier); 2006:488–492.Google Scholar
  11. 11.
    Fam AG. Paraneoplastic rheumatic syndromes. Baillieres Clin Rheumatol 2000;14:515–533.CrossRefGoogle Scholar
  12. 12.
    Fam AG, Kolin A, Lewis AJ. Metastatic carcinomatous arthritis and carcinoma of the lung. A report of two cases diagnosed by synovial fluid cytology. J Rheumatol 1980;7:98–104.Google Scholar
  13. 13.
    Evans TL, Nercessian BM, Sanders KM. Leukemic arthritis. Semin Arthritis Rheum 1994;24:48–56.CrossRefPubMedGoogle Scholar
  14. 14.
    Fam AG, Voorneveld C, Robinson JB, Sheridan BL. Synovial fluid immunocytology in the diagnosis of leukemic synovitis. J Rheumatol 1991;18:293–296.PubMedGoogle Scholar
  15. 15.
    Dorfman HD, Siegeel HL, Perry MC, Oxenhandler R. Non-Hodgkin’s lymphoma of the synovium simulating rheumatoid arthritis. Arthritis Rheum 1987;30:155–161.CrossRefPubMedGoogle Scholar
  16. 16.
    Tsochatzis A, Vassilopoulos D, Deutsch M, et al. Angiommunoblastic T-cell lymphoma-associated arthritis. Case report and literature review. J Clin Rheumatol 2005;11:326–328.Google Scholar
  17. 17.
    Roux S, Fermand J-P, Brechignac S, et al. Tumoral joint involvement in multiple myeloma and Waldenstrom’s macroglobulinemia – report of 4 cases. J Rheumatol 1996;23:1175–1178.Google Scholar
  18. 18.
    Fam AG, Rubenstein JD, Cowan DH. POEMS syndrome. Study of a patient with proteinuria, microangiopathic glomerulopathy and renal enlargement. Arthritis Rheum 1986;29:233–241.CrossRefPubMedGoogle Scholar
  19. 1.
    Pastan RS, Cohen AS. The rheumatologic manifestations of diabetes mellitus. Med Clin North Am 1978;62:829–839.PubMedGoogle Scholar
  20. 2.
    Crisp AJ, Heathcote JG. Connective tissue abnormalities in diabetes mellitus. J R Coll Phys Lond 1984;18:132–141.Google Scholar
  21. 3.
    Schulte L, Roberts MS, Zimmerman C, Ketler J, Simon LS. A quantitative assessment of limited joint mobility in patients with diabetes. Goniometric analysis of upper extremity passive range of motion. Arthritis Rheum 1993;36:1429–1443.CrossRefPubMedGoogle Scholar
  22. 4.
    Mavrikakis ME, Drimis S, Kontoyannis DA, Rasidakis A, Moulopoulou ES, Kontoyannis S. Calcific shoulder periarthritis (tendinitis) in adult onset diabetes mellitus: a controlled study. Ann Rheum Dis 1989;48:211–214.CrossRefPubMedGoogle Scholar
  23. 5.
    Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 1972;51:191–210.CrossRefGoogle Scholar
  24. 6.
    Krendel DA. Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus [see comments]. Arch Neurol 1995;52:1053–1061.PubMedGoogle Scholar
  25. 7.
    Grigoriadis E, Fam AG, Starok M, Ang LC. Skeletal muscle infarction in diabetes mellitus. J Rheumatol 2000;27:1063–1068.PubMedGoogle Scholar
  26. 8.
    Bland JH, Frymoyer JW. Rheumatic syndromes of myxedema. N Engl J Med 1970;282:1171–1174.CrossRefPubMedGoogle Scholar
  27. 9.
    Bland JH, Frymoyer JW, Newberg AH, Revers R, Norman R. Rheumatic syndromes in endocrine disease. Semin Arthritis Rheum 1979;9:23–65.CrossRefPubMedGoogle Scholar
  28. 10.
    Wartofsky L. Levothyroxine therapy and osteoporosis. An end to the controversy? Arch Intern Med 1995;155:1130–1131.CrossRefPubMedGoogle Scholar
  29. 11.
    Merkel P. Drugs associated with vasculitis. Curr Opin Rheumatol 1998;10:45–50.CrossRefPubMedGoogle Scholar
  30. 12.
    Alexander GM, Dieppe PA, Doherty M, Scott DG. Pyrophosphate arthropathy: a study of metabolic associations and laboratory data. Ann Rheum Dis 1982;41:377–381.CrossRefPubMedGoogle Scholar
  31. 13.
    Bluestone R, Bywaters EG, Hartog M, Holt PJ, Hyde S. Acromegalic arthropathy. Ann Rheum Dis 1971;30:243–258.CrossRefPubMedGoogle Scholar
  32. 14.
    Phillips KA, Nance EP Jr, Rodriguez RM, Kaye JF. Avascular necrosis of bone: a manifestation of Cushing’s disease. South Med J 1986;79:825–829.PubMedGoogle Scholar
  33. 15.
    Plonk JW, Feldman JM. Carcinoid arthropathy. Arch Intern Med 1974;134:651–654.CrossRefPubMedGoogle Scholar
  34. 1.
    Fredrickson DS, Levy RI, Lees RS. Fat transport in lipoproteins: an integrated approach to mechanisms and disorders. N Engl J Med 1967;276:34–42, 94–103, 148–156, 215–225, 273–281.CrossRefPubMedGoogle Scholar
  35. 2.
    Fahey JJ, Stark HH, Donovan WE, Drennan DB. Xanthoma of the Achilles tendon. J Bone Joint Surg Am 1973;55A:1197–1211.Google Scholar
  36. 3.
    Yaghami I. Intra- and extraosseous xanthomata associated with hyperlipidemia. Radiology 1978;128:49–54.Google Scholar
  37. 4.
    Shapiro R, Fallat RW, Tsang RC, Glueck CJ. Achilles tendinitis and tenosynovitis. Am J Dis Child 1974;128:486–490.PubMedGoogle Scholar
  38. 5.
    Glueck CJ, Levy R, Fredrickson DS. Acute tendinitis and arthritis. A presenting symptom of familial type II hyper-lipoproteinemia. JAMA 1968;206:2895–2897.CrossRefPubMedGoogle Scholar
  39. 6.
    Bardin T, Kuntz D. Primary hyperlipidemias and xanthomatosis. In: Klippel JH, Dieppe P (eds). Rheumatology. London: Times Mirror International Publishers Limited; 1994;27.1–27.4.Google Scholar
  40. 7.
    Siegelman SS, Schlossberg I, Becker NH, Sachs BA. Hyperlipoproteinemia with skeletal lesions. Clin Orthop 1972;87:228–232.PubMedGoogle Scholar
  41. 8.
    Truswell AS, Pfister PJ. Cerebrotendinous xanthomatosis. Br Med J 1972;1:353–354.CrossRefPubMedGoogle Scholar
  42. 9.
    Shulman RS, Bhattacharyya AK, Connor WE, Fredrickson DS. Beta-sitosterolemia and xanthomatosis. N Engl J Med 1976;294:482–483.CrossRefPubMedGoogle Scholar
  43. 10.
    Rooney PJ, Third J, Madkour MM, Spencer D, Dick WC. Transient polyarthritis associated with familial hyperbetal lipoproteinemia. Q J Med 1978;47:249–259.PubMedGoogle Scholar
  44. 11.
    Mathon G, Gagne C, Brun D, Lupien PJ, Moorjani S. Articular manifestations of familial hypercholesterolemia. Ann Rheum Vis 1985;44:599–602.CrossRefGoogle Scholar
  45. 12.
    Welin L, Larsson B, Svardsudd K, Tibblin G. Serum lipids, lipoproteins and musculoskeletal disorders among 50- and 60-year-old men. Scand J Rheumatol 1977;1:7–12.Google Scholar
  46. 13.
    Struthers GR, Scott DL, Bacon PA, Walton KW. Musculoskeletal disorders in patients with hyperlipidemia. Ann Rheum Dis 1983;42:519–523.CrossRefPubMedGoogle Scholar
  47. 14.
    Wysenbeek AJ, Shani E, Beigel Y. Musculoskeletal manifestations in patients with hypercholesterolemia. J Rheumatol 1989;16:643–645.PubMedGoogle Scholar
  48. 15.
    Klemp P, Halland AM, Majoos FL, Steyn K. Musculo-skeletal manifestations in hyperlipidemia: a controlled study. Ann Rheum Dis 1993;52:44–48.CrossRefPubMedGoogle Scholar
  49. 16.
    Khachadurian AK. Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia). Arthritis Rheum 1968;11:385–393.CrossRefPubMedGoogle Scholar
  50. 17.
    Rimon D, Cohen L. Hypercholesterolemic (type II hyperlipoproteinemic) arthritis. Rheumatology 1989;16:703–705.Google Scholar
  51. 18.
    Buckingham RB, Bole GG, Bassett DR. Polyarthritis associated with type IV hyperlipoproteinemia. Arch Intern Med 1975;135:286–290.CrossRefPubMedGoogle Scholar
  52. 19.
    Lazarevic MB, Skosey JL, Vitic J, et al. Cholesterol crystals in synovial and bursal fluid. Semin Arthritis Rheum 1993;23:99–103.CrossRefGoogle Scholar
  53. 20.
    Schumacher HR, Michaels R. Recurrent tendinits and Achilles tendon nodule with positively birefringent crystals in a patient with hyperlipoprotenemia. J Rheumatol 1989;16:1387–1389.PubMedGoogle Scholar
  54. 21.
    Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs. Arthritis Rheum 2006;54:1378–1389.CrossRefPubMedGoogle Scholar
  55. 1.
    Gupta A. A short history of neuropathic arthropathy. Clin Orthop 1993;296:43–49.PubMedGoogle Scholar
  56. 2.
    Lee L, Blume P, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg 2003;17:571–580.CrossRefPubMedGoogle Scholar
  57. 3.
    Resnick D. Neuropathic osteoarthropathy. In: Resnick D, ed. Diagnosis of bone and joint disorders. 3rd ed. Philadelphia: Saunders; 1995:3413–3442.Google Scholar
  58. 4.
    Sinacore D, Withrington N. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther 1999;29:736–746.PubMedGoogle Scholar
  59. 5.
    Fishco W. Surgically induced Charcot’s foot. J Am Podiatr Med Assoc 2001;91:288–293.Google Scholar
  60. 6.
    Eichenholtz S. Charcot joints. Springfield: Thomas; 1966.Google Scholar
  61. 7.
    Sloman-Kovacs S, Braunstein E, Brandt K. Rapidly progressive Charcot arthropathy following minor joint trauma in patients with diabetic neuropathy. Arthritis Rheum 1990;33:412–417.CrossRefGoogle Scholar
  62. 8.
    Lipman B, Collier B, Carrera G, et al. Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI, and conventional radiography. Clin Nucl Med 1998;23:77–82.CrossRefPubMedGoogle Scholar
  63. 9.
    Palestro C, Mehta H, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998;39:346–350.PubMedGoogle Scholar
  64. 10.
    Saltzman C, Hagy M, Zimmerman B, Estin M, Cooper R. How effective is intensive nonoperative intial treatment of patients with diabetes and Charcot arthropathy of the feet? Clin Orthop 2005;435:185–190.PubMedGoogle Scholar
  65. 1.
    Callen JP. Miscellaneous disorders that commonly affect both skin and joints. In: Sontheimer RD, Provost TT, eds. Cutaneous manifestations of rheumatic diseases. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004:221–241.Google Scholar
  66. 2.
    Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol 2003;42:761–778.CrossRefPubMedGoogle Scholar
  67. 3.
    Jackson JM, Callen JP. Pyoderma gangrenosum. An expert commentary. Int J Dermatol 2006;41:916–918.Google Scholar
  68. 4.
    Walling HW, Snipes CJ, Gerami P, Piette WW. The relationship between neutrophilic dermatosis of the dorsal hands and sweet syndrome: report of 9 cases and comparison to atypical pyoderma gangrenosum. Arch Dermatol 2006;142:57–63.CrossRefPubMedGoogle Scholar
  69. 5.
    Brown TB, Fearneyhough PF, Burruss JB, Callen JP. Rheumatoid neutrophilic dermatitis in a woman with seronegative rheumatoid arthritis. J Am Acad Dermatol 2001;45:596–600.CrossRefPubMedGoogle Scholar
  70. 6.
    Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol 2001;45:163–183.CrossRefPubMedGoogle Scholar
  71. 7.
    Requena L, Sanchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 2001;45:325–361.CrossRefPubMedGoogle Scholar
  72. 8.
    Requena L, Requena C. Erythema nodosum. Dermatol Online J 2002;8:4.PubMedGoogle Scholar
  73. 9.
    Bruce AJ, Bennett DD, Lohse CM, Rooke TW, Davis MD. Lipodermatosclerosis: review of cases evaluated at Mayo Clinic. J Am Acad Dermatol 2002;46:187–192.CrossRefPubMedGoogle Scholar
  74. 10.
    Ma L, Bandarchi B, Glusac EJ. Fatal subcutaneous panniculitis-like T-cell lymphoma with interface change and dermal mucin, a dead ringer for lupus erythematosus. J Cutan Pathol 2005;32:360–365.CrossRefPubMedGoogle Scholar
  75. 11.
    Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005;52:2873–2881.CrossRefPubMedGoogle Scholar
  76. 12.
    Oyama N, Chan I, Neill SM, et al. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest 2004;113:1550–1559.PubMedGoogle Scholar
  77. 13.
    Donato ML, Feasel AM, Weber DM, et al. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood 2006;107:463–466.CrossRefPubMedGoogle Scholar
  78. 14.
    Cowper SE, Boyer PJ. Nephrogenic systemic fibrosis: an update. Curr Rheumatol Rep 2006;8:151–157.CrossRefPubMedGoogle Scholar
  79. 15.
    Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum 2005;52:2513–2518.CrossRefPubMedGoogle Scholar
  80. 16.
    Suei Y, Taguchi A, Tanimoto K. Diagnostic points and possible origin of osteomyelitis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: a radiographic study of 77 mandibular osteomyelitis cases. Rheumatology (Oxford) 2003;42:1398–1403.CrossRefGoogle Scholar
  81. 17.
    Mehrany K, Kist JM, Weenig RH, Witman PM. Acne fulminans. Int J Dermatol 2005;44:132–133.CrossRefPubMedGoogle Scholar
  82. 18.
    Hairston BR, Davis MDP, Pittelkow MR, Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006;142:1413–1418.CrossRefPubMedGoogle Scholar
  83. 19.
    McDermott MB, Lind AC, Marley EF, Dehner LP. Deep granuloma annulare (pseudorheumatoid nodule) in children: clinicopathologic study of 35 cases. Pediatr Dev Pathol 1998;1:300–308.CrossRefPubMedGoogle Scholar
  84. 20.
    Brey NV, Malone J, Callen JP. Acute-onset, painful acral granuloma annulare: a report of 4 cases and a discussion of the clinical and histologic spectrum of the disease. Arch Dermatol 2006;142:49–54.CrossRefPubMedGoogle Scholar
  85. 21.
    Chu P, Connolly MK, LeBoit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol 1994;130:1278–1283.CrossRefPubMedGoogle Scholar
  86. 1.
    Martínez-Lavín M, Matucci-Cerinic M, Pineda C, et al. Hypertrophic osteoarthropathy: consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol 1993;20:1386–1387.PubMedGoogle Scholar
  87. 2.
    Silveira L, Martínez-Lavín M, Pineda C, Navarro C, Fonseca MC, Nava A. Vascular endothelial growth factor in hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000;18:57–62.PubMedGoogle Scholar
  88. 3.
    Vazquez-Abad D, Martínez-Lavín M. Macrothrombocytes in the peripheral circulation of patients with cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol 1991;9:59–62.PubMedGoogle Scholar
  89. 4.
    Olan F, Portela M, Navarro C, Gaxiola M, Silveira V, Martinez-Lavin M. Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity. J Rheumatol 2004;31:614–616.PubMedGoogle Scholar
  90. 5.
    Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol 2004;203:721–728.CrossRefPubMedGoogle Scholar
  91. 6.
    Vazquez-Abad D, Martínez-Lavín M. Digital clubbing: a numerical assessment of the deformity. J Rheumatol 1989;16:518–520.PubMedGoogle Scholar
  92. 7.
    Martínez-Lavín M, Pineda C, Valdéz T, et al. Primary hypertrophic osteoarthropathy. Semin Arthritis Rheum 1988;17:156–162.CrossRefPubMedGoogle Scholar
  93. 8.
    Pineda C, Fonseca C, Martínez-Lavín M. The spectrum of soft tissue and skeletal abnormalities in hypertrophic osteoarthropathy. J Rheumatol 1990;17:773–778.Google Scholar
  94. 9.
    Martínez-Lavín M, Vargas AS, Cabré J, et al. Features of hypertrophic osteoarthropathy in patients with POEMS syndrome. A metaanalysis. J Rheumatol 1997;24:2267–2268.Google Scholar
  95. 10.
    Guyot-Drouot MH, Solau-Grvais E, Cortet B, et al. Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. J Rheumatol 2000;27:2418–2423.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Adel G. Fam
    • 1
  1. 1.Department of Medicine, Division of RheumatologySunnybrook & Women’s College Health Sciences Centre, University of TorontoTorontoCanada

Personalised recommendations